SCHEMBL12201346

SCHEMBL12201346

C/C(=N/O)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
CA4 P22748 1/20 0.40
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
HSP90AA1 P07900 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 2/20 0.38
ATM Q13315 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LTA4H P09960 1/20 0.38
TSHR P16473 1/20 0.38
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 1/20 0.36
CA5A P35218 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
CTBP2 P56545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8973386 1.00 ELANE (0.41) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL10670243 0.92 LTA4H (0.48) ELANEMAPTALDH1A1LTA4HTSHR
SCHEMBL15891862 0.81 ELANE (0.41) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL7301000 0.81 ELANE (0.41) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL9386802 0.81 ELANE (0.41) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL5918161 0.79 ESR2 (0.44) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL14667469 0.77 CA4 (0.42) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL26413602 0.76 MAPT (0.41) ELANEMAPTALDH1A1CA4KDM4E
SCHEMBL12228517 0.75 LTA4H (0.41) MAPTALDH1A1CA4KDM4ETDP1
Hydrochloric Acid SCHEMBL6187430 0.74 MAPT (0.40) ELANEMAPTALDH1A1CA4LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110245223-A1 HETEROCYCLIC COMPOUNDS JAPAN TOBACCO INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245223-A1 HETEROCYCLIC COMPOUNDS HSD11B1, HSD11B2, CYP11B1 ELANE 1347/4885MAPT 4183/4885ALDH1A1 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.